SG11201401770YA - Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition - Google Patents

Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition

Info

Publication number
SG11201401770YA
SG11201401770YA SG11201401770YA SG11201401770YA SG11201401770YA SG 11201401770Y A SG11201401770Y A SG 11201401770YA SG 11201401770Y A SG11201401770Y A SG 11201401770YA SG 11201401770Y A SG11201401770Y A SG 11201401770YA SG 11201401770Y A SG11201401770Y A SG 11201401770YA
Authority
SG
Singapore
Prior art keywords
delivery
drug
manufacturing
composition
polymeric
Prior art date
Application number
SG11201401770YA
Other languages
English (en)
Inventor
Andreas Voigt
Jörg Kriwanek
Andreas Reiff
Scott Hampton
Sonja Lehmann
Original Assignee
Therakine Biodelivery Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therakine Biodelivery Gmbh filed Critical Therakine Biodelivery Gmbh
Publication of SG11201401770YA publication Critical patent/SG11201401770YA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG11201401770YA 2011-11-30 2012-11-29 Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition SG11201401770YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/307,474 US9474715B2 (en) 2011-11-30 2011-11-30 Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition
PCT/EP2012/073983 WO2013079605A2 (en) 2011-11-30 2012-11-29 Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition

Publications (1)

Publication Number Publication Date
SG11201401770YA true SG11201401770YA (en) 2014-09-26

Family

ID=47278823

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201401770YA SG11201401770YA (en) 2011-11-30 2012-11-29 Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition

Country Status (12)

Country Link
US (2) US9474715B2 (de)
EP (1) EP2785330B1 (de)
JP (1) JP2015502354A (de)
KR (1) KR20140097541A (de)
CN (1) CN104105480A (de)
AU (1) AU2012343854A1 (de)
BR (1) BR112014011609A2 (de)
CA (1) CA2856794A1 (de)
ES (1) ES2637379T3 (de)
RU (1) RU2014126347A (de)
SG (1) SG11201401770YA (de)
WO (1) WO2013079605A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3204044A4 (de) * 2014-10-07 2018-10-03 Andreas Voigt Mikronisiertes freisetzungsmaterial, verfahren zur herstellung davon und verfahren zur anwendung
WO2016067252A1 (en) 2014-10-31 2016-05-06 Glaxosmithkline Intellectual Property Development Limited Powder formulation
GB201500430D0 (en) 2015-01-12 2015-02-25 Univ Birmingham Dressing
EP3658114A1 (de) * 2017-07-25 2020-06-03 Pk Med Sas Zusammensetzung zur wirkstofffreisetzung
WO2019073361A1 (en) * 2017-10-12 2019-04-18 Solyplus Berlin Gmbh MECHANICAL TREATMENT OF BIOPOLYMERS
BR112020006808A2 (pt) * 2017-10-12 2020-10-06 Solyplus Berlin Gmbh método de processamento para biopolímeros utilizando combinações de solvente
CN109529116B (zh) * 2019-01-29 2019-12-31 中国海洋大学 一种用于治疗烫伤的ns-gam基因活性支架及其制备方法
EP3811982A1 (de) * 2019-10-25 2021-04-28 Université de Strasbourg Biomaterial auf proteinbasis mit viskoelastischem verhalten, verfahren zur herstellung davon und verwendungen davon
EP4069324A4 (de) * 2019-12-06 2024-01-10 Guangzhou Bioseal Biotech Co Ltd Fliessfähige fibrinogenthrombinpaste

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1540979A (en) 1923-04-11 1925-06-09 Swift & Co Machine for testing jelly strength of glues, gelatins, and the like
US5876754A (en) 1992-01-17 1999-03-02 Alfatec-Pharma Gmbh Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies
JPH06218028A (ja) * 1992-10-02 1994-08-09 Eisai Co Ltd 湿製錠の成型方法とその装置及び湿製錠
NZ273865A (en) * 1993-09-20 1997-12-19 Anadis Ltd Obtaining high purity ig from antibody rich colostrum and compositions thereof
US5674495A (en) 1995-02-27 1997-10-07 Purdue Research Foundation Alginate-based vaccine compositions
FI103207B1 (fi) 1996-08-27 1999-05-14 Sune Backlund Immobilisoidun entsyymin sisältävä geeli
IT1297461B1 (it) 1997-10-29 1999-12-17 Ciocca Maurizio Preparazione di compresse a rilascio controllato a base di complessi tra carragenano e farmaci basici solubili
AU6318900A (en) * 1999-08-05 2001-03-05 Takeda Chemical Industries Ltd. Pastes with the sustained release of osteogenesis promoter
AU4724401A (en) * 2000-02-28 2001-09-12 Genesegues Inc Nanocapsule encapsulation system and method
US7141555B2 (en) 2000-12-19 2006-11-28 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
AUPR272901A0 (en) 2001-01-25 2001-02-22 Gainful Plan Limited Method of preparing biological materials and preparations produced using same
US20070059336A1 (en) 2004-04-30 2007-03-15 Allergan, Inc. Anti-angiogenic sustained release intraocular implants and related methods
CN1993060A (zh) 2004-08-19 2007-07-04 帝斯曼知识产权资产管理有限公司 可脂溶物质的新型组合物
KR20080016780A (ko) 2004-11-24 2008-02-22 테라킨 리미티드 안내 약물 전달용 임플란트
BRPI0621761A2 (pt) 2006-06-12 2011-12-20 Therakine Ltd solução oftálmica e uso de uma solução salina, e uma quantidade eficaz de pelo menos um agente terapêutico
US8039010B2 (en) 2006-11-03 2011-10-18 Allergan, Inc. Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier
WO2010089104A2 (en) 2009-02-04 2010-08-12 Dsm Ip Assets B.V. Resveratrol compositions

Also Published As

Publication number Publication date
CA2856794A1 (en) 2013-06-06
EP2785330B1 (de) 2017-03-29
US20130136774A1 (en) 2013-05-30
KR20140097541A (ko) 2014-08-06
JP2015502354A (ja) 2015-01-22
WO2013079605A3 (en) 2013-08-29
WO2013079605A2 (en) 2013-06-06
BR112014011609A2 (pt) 2017-05-30
EP2785330A2 (de) 2014-10-08
US9474715B2 (en) 2016-10-25
AU2012343854A1 (en) 2014-05-08
CN104105480A (zh) 2014-10-15
US20170095419A1 (en) 2017-04-06
RU2014126347A (ru) 2016-01-27
ES2637379T3 (es) 2017-10-13

Similar Documents

Publication Publication Date Title
SG11201401765TA (en) Hydrophobic drug-delivery material, method for manufacturing thereof and methods for delivery of a drug-delivery composition
SG11201401770YA (en) Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition
HK1187654A1 (en) Antimicrobial substance, method for producing same, and antimicrobial material
EP2672539A4 (de) Piezoelektrisches polymermaterial und herstellungsverfahren dafür
EP2805734A4 (de) Antimikrobielles wundenabdeckmaterial und herstellungsverfahren dafür
EP2662910A4 (de) Polymeres piezoelektrisches material und verfahren zu seiner herstellung
EP2660262A4 (de) Verfahren zur herstellung eines harzes für für optisches material auf urethanbasis, harzzusammensetzung dafür und hergestelltes optisches material
EP2700399A4 (de) Arzneimittelabgabepartikel und verfahren zu ihrer herstellung
SG10201508662SA (en) Methods for drug delivery
EP2691126A4 (de) Vorrichtungen und verfahren für intraokulare wirkstofffreisetzung
EP2874209A4 (de) Verfahren zur herstellung eines beschichteten aktivmaterials
EP2710994A4 (de) Zahnärztliches material, zusammensetzung mit dem zahnärztlichen material, zahnärztliches reparaturmaterial und gehärtetes produkt
EP2702103A4 (de) Mischungszusammensetzung, flexibles schlauchmaterial und verfahren zur herstellung der mischung
EP2765996A4 (de) Nanopartikel zur blutstillung und wirkstofffreisetzung
EP2643009A4 (de) Zusammensetzung zur freisetzung biologisch abbaubarer wirkstoffe
PL2665431T3 (pl) Technika dostarczania leków
EP2835373A4 (de) Epoxidverbindung mit einer alkoxysilylgruppe, zusammensetzung und gehärtetes material damit, verwendung davon und verfahren zur herstellung einer epoxidverbindung mit einer alkoxysilylgruppe
EP2760069A4 (de) Elektrodenmaterial, elektrode und herstellungsverfahren für elektrodenmaterial
IL230998A0 (en) Drug release system and production methods
EP2679608A4 (de) Hochkonzentriertes polymerpolyol und herstellungsverfahren dafür
EP2718097A4 (de) Materialzusammensetzung, laminatrohr und herstellungsverfahren dafür
SG11201402185YA (en) Construction material mixture, a method for producing same, and use thereof
IL254182A0 (en) Drug release system and production methods
EP2885045A4 (de) Verfahren zur herstellung von arzneistoffformulierungen
EP2634149A4 (de) Pulvermaterial, verfahren zur herstellung einer kommunikationsvorrichtung und kommunikationsvorrichtung